soul trial oral semaglutide cardiovascular outcomes 2024 results mace SOUL: Bests Usual Care in High-Risk Type 2 Diabetes SELECT Trial

Examples may include: Semaglutide Tirzepatide CJC-1295 with DAC These peptides are specifically engineered to resist rapid enzymatic breakdown and remain active longer in the body

Ideal Candidates You're likely a good candidate if you have BMI of 30+ (obesity) or 27+ with weight-related health conditions, have tried diet and exercise without sustained success, are ready to commit to healthier eating, want medically supervised, FDA-approved treatment, and can invest 6-12 months for optimal results

Always default to the shorter end of that range and consult the specific compound's documentation, since longer, more complex peptide chains generally degrade faster than short, stable sequences

doi: 10.1097/mca.0000000000000830 13 SilverHJOlsonDMayfieldDWrightPNianHMashayekhiMet al